Clinical Trial Update: Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

View source ↗

Summary

Observational study evaluating the safety, efficacy, and convenience of using NovoMix 30 FlexPen in individuals with type 2 diabetes; the study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoMix 30 FlexPen (insulin lispro protamine suspension)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED